Suppr超能文献

硝苯地平-阿替洛尔联合用药对动脉肌细胞迁移和增殖的影响。

Effect of the nifedipine-atenolol association on arterial myocyte migration and proliferation.

作者信息

Corsini A, Quarato P, Raiteri M, Paubert-Braquet M, Nguyen G, Picquot S, Bourgain R H, Fumagalli R, Paoletti R

机构信息

Institute of Pharmacological Sciences, University of Milan, Italy.

出版信息

Pharmacol Res. 1993 May-Jun;27(4):299-307. doi: 10.1006/phrs.1993.1030.

Abstract

The in vitro effect of nifedipine and atenolol, either alone or in combination, on the proliferation and migration of rat aortic smooth muscle cells was investigated. Nifedipine inhibited the replication of arterial myocytes in concentrations ranging between 10 and 100 microM. The inhibition, evaluated as cell number, was dose- and time-dependent with an IC50 of 39 and 34 microM after 48 and 72 h, respectively; the cell doubling time increased with drug concentrations up to 118 h versus 28 h for controls. Atenolol alone failed to reduce arterial myocyte proliferation, and did not influence the effect of nifedipine on cell proliferation. Nifedipine and atenolol alone inhibited in a dose-dependent manner rat aortic myocytes migration induced by fibrinogen as chemotactic agent. When the combination nifedipine-atenolol was investigated, an additive inhibitory effect on cell migration was observed. These results provide in vitro support for a potential effect of this drug association on early steps of atherogenesis.

摘要

研究了硝苯地平与阿替洛尔单独或联合使用对大鼠主动脉平滑肌细胞增殖和迁移的体外作用。硝苯地平在10至100微摩尔浓度范围内抑制动脉肌细胞的复制。以细胞数量评估,抑制作用呈剂量和时间依赖性,48小时和72小时后的IC50分别为39和34微摩尔;细胞倍增时间随药物浓度增加而延长,最高可达118小时,而对照组为28小时。单独使用阿替洛尔未能降低动脉肌细胞增殖,且不影响硝苯地平对细胞增殖的作用。硝苯地平和阿替洛尔单独使用时均以剂量依赖方式抑制由纤维蛋白原作为趋化剂诱导的大鼠主动脉肌细胞迁移。当研究硝苯地平 - 阿替洛尔组合时,观察到对细胞迁移有相加抑制作用。这些结果为这种药物联合使用对动脉粥样硬化早期阶段的潜在作用提供了体外支持。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验